Literature DB >> 15181456

Galectin-1beta, a natural monomeric form of galectin-1 lacking its six amino-terminal residues promotes axonal regeneration but not cell death.

T Miura1, M Takahashi, H Horie, H Kurushima, D Tsuchimoto, K Sakumi, Y Nakabeppu.   

Abstract

We previously identified a novel N-terminally processed form of galectin-1, galectin-1beta (Gal-1beta) whose expression was induced by DeltaFosB. In the present study, the biochemical properties and biological functions of Gal-1beta were compared with the full-length form of galectin-1 (Gal-1alpha). We first purified recombinant mouse Gal-1alpha and beta (rmGal-1alpha, beta) to near homogeneity. The rmGal-1alpha exists as a monomer under oxidized conditions and forms a dimer under reduced conditions, while the rmGal-1beta exists as a monomer regardless of redox conditions. The affinity of rmGal-1beta to beta-lactose was approximately two-fold lower than that of rmGal-1alpha under reduced conditions. The viability of Jurkat cells efficiently decreased when they were exposed to rmGal-1alpha, however, rmGal-1beta barely induced such a reduction. In contrast, both rmGal-1alpha and rmGal-1beta exhibited an equivalent capacity to promote axonal regeneration from the dorsal root ganglion explants. Our results suggest that the biochemical properties of rmGal-1beta determine its biological functions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15181456     DOI: 10.1038/sj.cdd.4401462

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  12 in total

Review 1.  Engineering galectin-glycan interactions for immunotherapy and immunomodulation.

Authors:  Shaheen A Farhadi; Gregory A Hudalla
Journal:  Exp Biol Med (Maywood)       Date:  2016-05

2.  Site-Specific Cross-Linking of Galectin-1 Homodimers via Poly(ethylene glycol) Bismaleimide.

Authors:  Bryant J Kane; Margaret M Fettis; Shaheen A Farhadi; Renjie Liu; Gregory A Hudalla
Journal:  Cell Mol Bioeng       Date:  2021-06-04       Impact factor: 3.337

3.  Antibody-dependent enhancement of hepatitis C virus infection.

Authors:  Keith Meyer; Malika Ait-Goughoulte; Zhen-Yong Keck; Steven Foung; Ranjit Ray
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

4.  Ligand reduces galectin-1 sensitivity to oxidative inactivation by enhancing dimer formation.

Authors:  Sean R Stowell; Moonjae Cho; Christa L Feasley; Connie M Arthur; Xuezheng Song; Jennifer K Colucci; Sougata Karmakar; Padmaja Mehta; Marcelo Dias-Baruffi; Rodger P McEver; Richard D Cummings
Journal:  J Biol Chem       Date:  2008-12-22       Impact factor: 5.157

5.  Cell-surface receptor control that depends on the size of a synthetic equilateral-triangular RNA-protein complex.

Authors:  Yoshihiko Fujita; Rie Furushima; Hirohisa Ohno; Fumihiko Sagawa; Tan Inoue
Journal:  Sci Rep       Date:  2014-09-19       Impact factor: 4.379

Review 6.  Galectins as Molecular Targets for Therapeutic Intervention.

Authors:  Ruud P M Dings; Michelle C Miller; Robert J Griffin; Kevin H Mayo
Journal:  Int J Mol Sci       Date:  2018-03-19       Impact factor: 5.923

Review 7.  Regenerative medicine: could Parkinson's be the first neurodegenerative disease to be cured?

Authors:  Mariacruz L Díaz
Journal:  Future Sci OA       Date:  2019-10-10

8.  Galectin-1 is an interactive protein of selenoprotein M in the brain.

Authors:  Xifeng Qiao; Jing Tian; Ping Chen; Chao Wang; Jiazuan Ni; Qiong Liu
Journal:  Int J Mol Sci       Date:  2013-11-11       Impact factor: 5.923

9.  Galectin-1 expression in innervated and denervated skeletal muscle.

Authors:  Anna Svensson; Sven Tågerud
Journal:  Cell Mol Biol Lett       Date:  2008-10-10       Impact factor: 5.787

10.  Animal Galectins and Plant Lectins as Tools for Studies in Neurosciences.

Authors:  João Ronielly Campêlo Araújo; Cauê Barbosa Coelho; Adriana Rolim Campos; Renato de Azevedo Moreira; Ana Cristina de Oliveira Monteiro-Moreira
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.